A detailed history of Hhm Wealth Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Hhm Wealth Advisors, LLC holds 30 shares of RGEN stock, worth $4,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 30 -0.0%
Holding current value
$4,645
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$140.68 - $188.02 $3,517 - $4,700
-25 Reduced 45.45%
30 $5,000
Q4 2021

Feb 03, 2022

BUY
$247.59 - $304.47 $7,427 - $9,134
30 Added 120.0%
55 $15,000
Q2 2021

Jul 27, 2021

BUY
$165.87 - $220.95 $4,146 - $5,523
25 New
25 $5,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Hhm Wealth Advisors, LLC Portfolio

Follow Hhm Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hhm Wealth Advisors, LLC with notifications on news.